You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Patent: 9,358,270


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,358,270
Title:Method of treating rhinitis with B-type and C-type natriuretic peptides
Abstract: The problem to be solved by the present invention is to provide an effective and safe therapeutic preparation for rhinitis, which not only has significant effects on improvement in rhinitis, in particular allergic rhinitis, but also is rapid in manifestation of efficacy, fast-acting, and long-lasting, without local side effects. Means for solving the problem is a therapeutic preparation for rhinitis, in particular allergic rhinitis, comprising C-type natriuretic peptide (CNP) or B-type natriuretic peptide (BNP) as the active ingredient.
Inventor(s): Endo; Kyoko (Sendai, JP)
Assignee: IGISU Co., Ltd. (Tokyo, JP) Endo; Kyoko (Sendai, JP) Endo; Yori (Sendai, JP)
Application Number:14/193,017
Patent Claims:see list of patent claims

Details for Patent 9,358,270

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Allermed Laboratories, Inc. N/A animal allergens, standardized cat hair Injection 103473 03/12/1974 ⤷  Try a Trial 2029-08-27
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.